Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.81
-0.27 (-2.68%)
Apr 28, 2026, 4:00 PM EDT - Market closed
CRBP Stock Forecast
Stock Price Forecast
The 5 analysts that cover CRBP stock have a consensus rating of "Strong Buy" and an average price target of $45.6, which forecasts a 364.83% increase in the stock price over the next year. The lowest target is $38 and the highest is $57.
Price Target: $45.6 (+364.83%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 10, 2026.
Analyst Ratings
The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $53 → $57 | Buy | Maintains | $53 → $57 | +481.04% | Mar 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +440.27% | Nov 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $31 → $38 | Buy | Maintains | $31 → $38 | +287.36% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +307.75% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +307.75% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
1.70M
Revenue Next Year
3.67M
from 1.70M
Increased by 116.00%
EPS This Year
-4.68
from -5.90
EPS Next Year
-5.00
from -4.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.5M | 21.0M | ||||||
| Avg | 1.7M | 3.7M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,135.3% | ||||||
| Avg | - | 116.0% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.26 | -2.45 | ||||||
| Avg | -4.68 | -5.00 | ||||||
| Low | -5.63 | -7.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.